She specialized in Obstetrics / Gynaecology, since she excelled in the entrance examinations under the auspices of the Cyprus Ministry of Health and she acquired the specialist’s title from the Academic Hospital of Alexandroupolis.
She has worked at Harris Birthright Research Centre for Fetal Medicine at King’s College Hospital in London for two years next to the Professor Cyprus Nicolaides and specialized in the following:
First Trimester Ultrasound Control for Down syndrome and other similar issues by controlling the nuchal translucency, the nasal bone, the flow in the tricuspid valve and the flow in the ductus venosus of the fetus liver.
Second Trimester Ultrasound Control for any fetal congenital abnormalities and detailed anatomical control.
Doppler study and fetal growth ultrasound in the 2nd and 3rd trimester.
Doppler study of uterine arteries for risk calculation of pre-eclampsia / residual fetal development.
Cervix length measurement and calculation of premature birth risk.
Fetal echocardiography – Fetal cardiac specific control with certifications and training from the leader of this field, the Professor Lindsey Allan.
Counseling in complicated pregnancies (congenital fetal abnormalities, awareness in Rhesus anemia factor, gestational diabetes / pre-existing diabetes, residual fetal development, multiple pregnancy, congenital infections, etc.)
Amniocentesis and chorionic villus sampling to exclude any chromosomal and other genetic abnormalities.
Reduction of multiple gestations, discharge paracentesis poly hydramnios etc.
She has also worked at the University College Hospital of London (UCLH) and the private medical center Fetal Medicine Centre in Harley Street – London.
Important publications of the doctor are:
- Meta-analysis of second-trimester markers for trisomy 21 (Ultrasound Obstet Gynecol. 2013 Mar;41(3):247-61. doi: 10.1002/uog.12364. Epub 2013 Jan 24.)
- Second-trimester screening for trisomy-21 using prefrontal space ratio (Fetal Diagn Ther. 2013; 34(1):50-5. doi: 10.1159/000350271. Epub 2013 May 25.)
- Maternal serum placental growth factor, pregnancy-associated plasma protein-a and free β-human chorionic gonadotrophin at 30-33 weeks in the prediction of pre-eclampsia (Fetal Diagn Ther. 2013; 33(3):164-72. doi: 10.1159/000345090. Epub 2013 Feb 20.)
Since March 2013 the doctor is working in the private center of feto-maternal medicine (Fetal Medicine Centre) in Limassol. The center was the first which introduced the non-invasive method of screening for chromosomal abnormalities by a simple blood sample from the pregnant woman (Harmony Prenatal Test), to Cyprus.